ASRT vs. INO
ASRT (Assertio Holdings, Inc.) and INO (Inovio Pharmaceuticals, Inc.) are both stocks. Both are in the Healthcare sector — ASRT in Drug Manufacturers - Specialty & Generic, INO in Biotechnology. At a 0.19 correlation, their price movements are largely independent.
Performance
ASRT vs. INO - Performance Comparison
Loading charts...
Returns By Period
ASRT
- 1D
- —
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
INO
- 1D
- -4.27%
- 1M
- 0.90%
- 6M
- -29.11%
- YTD
- -35.63%
- 1Y
- -16.42%
- 3Y*
- -44.27%
- 5Y*
- -59.20%
- 10Y*
- -36.74%
ASRT vs. INO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ASRT Assertio Holdings, Inc. | 159.10% | -30.59% | -18.59% | -75.12% | 97.25% | 52.40% | -71.39% | -65.37% | -55.16% | -55.33% |
INO Inovio Pharmaceuticals, Inc. | -35.63% | -4.92% | -70.10% | -67.31% | -68.74% | -43.62% | 168.18% | -17.50% | -3.15% | -40.49% |
Correlation
The correlation between ASRT and INO is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Dec 17, 2003 | 0.19 |
The correlation between ASRT and INO shifts across timeframes, from 0.11 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ASRT:
$151.20M
INO:
$60.02M
ASRT:
-$5.27
INO:
-$48.88
ASRT:
2.00
INO:
0.13
ASRT:
$102.16M
INO:
$0.00
ASRT:
$71.85M
INO:
-$1.50M
ASRT:
-$2.31M
INO:
-$22.01B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASRT vs. INO — Risk / Return Rank
ASRT
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
INO
ASRT vs. INO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Assertio Holdings, Inc. (ASRT) and Inovio Pharmaceuticals, Inc. (INO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASRT | INO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.04 | — |
| Calmar ratioReturn relative to maximum drawdown | — | -0.26 | — |
| Martin ratioReturn relative to average drawdown | — | -0.41 | — |
Loading charts...
Drawdowns
ASRT vs. INO - Drawdown Comparison
Loading charts...
Drawdown Indicators
| ASRT | INO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -99.95% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -63.41% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -92.44% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -99.10% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.72% | — |
Current DrawdownCurrent decline from peak | — | -99.95% | — |
Average DrawdownAverage peak-to-trough decline | — | -92.37% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 40.27% | — |
Volatility
ASRT vs. INO - Volatility Comparison
Loading charts...
Volatility by Period
| ASRT | INO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 13.05% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 57.28% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 78.44% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 85.71% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 93.22% | — |
Dividends
ASRT vs. INO - Dividend Comparison
Neither ASRT nor INO has paid dividends to shareholders.
Financials
ASRT vs. INO - Financials Comparison
This section allows you to compare key financial metrics between Assertio Holdings, Inc. and Inovio Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ASRT and INO have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for ASRT and INO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer